The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 337:794-795 September 11, 1997 Number 11
NextNext

Detection of Lyme Disease after OspA Vaccine

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
To the Editor: The diagnosis of a new Lyme disease infection by conventional assays may be difficult in persons who have antibodies to or immunologic memory of Borrelia burgdorferi proteins. This was the case in a recipient of vaccine containing recombinant outer-surface protein A (OspA) of B. burgdorferi (Connaught).1 Analysis of the antibody and antigen constituents of B. burgdorferi–specific immune complexes can distinguish between past and active infection in such patients.2,3

Several years before vaccination, a woman with Lyme disease documented by the presence of erythema migrans and by a positive polymerase-chain-reaction assay of a skin-biopsy specimen was successfully . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.